RNLXY · Renalytix plc
$4.15
-0.34 (-7.47%)
At close · Sep 4
Going-concern doubt
— flagged Nov 19, 2024
Substantial doubt about the company's ability to continue as a going concern.
“As a result of the Company's losses and its projected cash needs, as defined in the accounting literature, substantial doubt exists about the Company's ability to continue as a going concern. While subsequent to September 30, 2024, the company has successfully raised approximately $14.9 million, net of expenses, in new equity capital and restructured the existing long-term debt recorded on the balance sheet, the Company does have a history of operating losses and it has been expensive to deliver all of the milestones to commercialize the kidneyintelX.dkd test. … As such, management has concluded that there is a going concern uncertainty. The consolidated financial statements do not include any adjustments that may result from the outcome of this going concern uncertainty.”View the 10-Q filed Nov 19, 2024
Market Cap
$2.20M
Shares
529,930
Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.
Fails to Deliver History
| Settlement Date | Quantity | Price | Value |
|---|---|---|---|
| 2026-08-10 | 60,000 | $2.77 | $166,200 |
| 2026-08-04 | 20,675 | $2.14 | $44,245 |
| 2026-07-31 | 19 | $1.91 | $36 |
| 2026-07-15 | 5,713 | $1.91 | $10,912 |
| 2026-07-07 | 11,081 | $2.04 | $22,605 |
| 2026-07-02 | 86 | $1.70 | $146 |
| 2026-07-01 | 18,603 | $1.40 | $26,044 |
| 2026-06-30 | 20,340 | $1.31 | $26,645 |
| 2026-06-25 | 525 | $1.15 | $604 |
| 2026-06-12 | 2,749 | $1.19 | $3,271 |
| 2026-06-09 | 72 | $1.20 | $86 |
Showing 1–11 of 11 settlements